#DSMB

Eric Topol

EricTopol

My podcast w/ Paul Offit, one of the world's leading lights on vaccines, regarding #SARSCoV2 vaccine developmenthttps://www.medscape.com/viewarticle/936937 @MedscapeIt's rich and I'll summarize key points here 1. "It's

Dr. Sanjay Gupta

drsanjaygupta

I want to take a moment to explain the big vaccine news today. #Pfizer is reporting early data showing their vaccine is “more than 90%” effective in preventing COVID-19. I

Michelle Rheault

rheault_m

In 2016, NIDDK put out a request for proposals for clinical trials looking at the effect of lowering uric acid on progression of children with CKD. I put together the

G Kang

GKangInd

A thread on vaccine safety, adverse events following immunization (AEFI) and assessments that happen when vaccines are tested before licensure. WHO has a great course at https://vaccine-safety-training.org/home.html from which a

Mamas Mamas

mmamas1973

1. Clickbait title but content worth discussing- my thoughts over the next few tweetsQuestions around AMI definition. Dr Taggart and others were part of the discussions that agreed to AMI

Kai Kupferschmidt

kakape

Good vaccine news continues:@moderna_tx just announced its vaccine has shown 94,5% efficacy.In the study of more than 30,000 participants, 95 #covid19 cases were observed (starting two weeks after second dose):90

Dinesh S. Thakur

d_s_thakur

This is a limited point about availability of efficacy data for vaccines under development in the context of the approval for CovidShield and Covaxin in India. There have been many

Matthew Herder

cmrherder

Dear $PFE : Show us the data.https://twitter.com/FrancoiseBaylis/status/1325769880994504707 As reported in @statnews by @matthewherper, to its credit $PFE dropped the idea of running an interim analysis at the 32-case mark, waiting

Samuel Brown

DrSamuelBrown

Some thoughts about the RECOVERY-DEX preprint. First, some more clarity about why it stopped--it hit the target sample size. Oddly, no discussion about alpha spend or what the DSMB reviewed.

Charlotte Summers

charlot_summers

There seems to be some confusion, even @rcplondon, regarding what is known about the role of therapies targeting IL-6 in COVID-19 so I thought I would attempt a thread to

Dr. Angela Rasmussen

angie_rasmussen

This is reason for cautious optimism but...it’s still data by press release. We need any vaccine as soon as possible, but I’m pretty skeptical that this vaccine is going to

Robert W. Yeh MD MBA

rwyeh

This is pretty cool.#FauciGrandRounds Dr. Fauci "not naming names", but clearly not pulling punches. Thinks strategy of protecting nursing homes alone exposes large proportion of susceptible Americans at risk for

ForeBucks

Forepawz

Folks have been asking me, so I thought I'd arrange my thoughts into tweets! I'm impressed with the vaccine at 90% effectiveness! For reference, flu vaccines that are well-matched to

Seth Trueger

MDaware

this is an excellent pointsome of my COVID vaccine thoughts (thread)https://twitter.com/Theresa_Chapple/status/1333742249641914368 bottom line: vaccine, good. I will get vaccinated as soon as I can, which, as an ER doc, will

Francisco Marty, MD

FranciscoMarty_

It took a while to digest the details of over 600 pages, but here is my review and comparative analysis of the #ACTT2 trial that compared #baricitinib vs. #placebo among

David Benkeser

biosbenk

It’s been rightfully pointed out that OWS protocols have not been made public; suspicious given current political climate. Here’s a thread with reflections on designs for COVID vax trials that

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.